ad image

XELJANZ

1 / 1
U.S. Food & Drug Administration
Drug Risk

FDA Approves Boxed Warning About Increased Risk of Blood Clots and Death with Higher Dose of Xeljanz

U.S. Food & Drug Administration

PR-M07-19-NI-074Jul 29, 2019
Pfizer
Marketing Authorization

XELJANZ® (tofacitinib citrate) Receives Marketing Authorization in the European Union for Moderately to Severely Active Ulcerative Colitis

Pfizer

PR-M08-18-NI-024Aug 07, 2018
1 / 1